tiprankstipranks
Trending News
More News >
GeneTether Therapeutics, Inc. (TSE:RIZE)
:RIZE
Canadian Market

GeneTether Therapeutics, Inc. (RIZE) Income Statement

Compare
3 Followers

GeneTether Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), GeneTether Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GeneTether Therapeutics, Inc.'s net income was $-128.73K. See GeneTether Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 747.28K$ 1.72M$ 1.64M$ 71.96K$ 86.23K
Depreciation and Amortization
$ 747.28K$ 4.84K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ 0.00$ -1.71M$ -1.64M$ -71.96K$ -509.00
Operating Income
$ -747.28K$ -1.72M$ -1.64M$ -71.96K$ -86.23K
Other Income/Expenses
$ 58.92K$ 1.98K$ -677.00$ -1.00K$ -509.00
Pretax Income
$ -688.36K$ -1.72M$ -1.64M$ -72.97K$ -86.74K
Net Income
$ -688.36K$ -1.71M$ -1.64M$ -73.97K$ -86.74K
Per Share Metrics
Basic EPS
$ -0.01$ -0.04$ -0.04$ 0.00$ -0.12
Diluted EPS
$ -0.01$ -0.04$ -0.04$ 0.00$ -0.12
Weighted Average Shares Outstanding
46.41M 48.38M 46.01M 46.01M 702.00K
Weighted Average Shares Outstanding (Diluted)
46.41M 48.38M 46.01M 46.01M 702.58K
Currency in USD

GeneTether Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis